Sonoma Pharmaceuticals (SNOA) announced the registration of its hypochlorous acid-based acne products with the Medicines & Healthcare products Regulatory Agency to be sold through a U.K. health and beauty retailer and pharmacy chain across more than 1,200 stores throughout the United Kingdom.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNOA:
- 3 Penny Stocks to Watch Now, 3/11/25